Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

15.70
Delayed Data
As of Mar 22
 -0.65 / -3.98%
Today’s Change
7.65
Today|||52-Week Range
20.64
+29.75%
Year-to-Date

Today’s Trading

Previous close16.35
Today’s open16.30
Day’s range15.45 - 16.65
Volume127,716
Average volume (3 months)254,230
Market cap$450.2M
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+12.75%
Earnings growth (this year)+11.13%
Earnings growth (next 5 years)-18.10%
Revenue growth (last year)+30.11%
P/E ratioNM
Price/Sales4.37
Price/Book3.94

Competitors

 Today’s
change
Today’s
% change
LMATLeMaitre Vascular In...+0.05+0.21%
ATRSAntares Pharma Inc+0.15+5.66%
CERSCerus Corp-0.07-1.69%
ELOSSyneron Medical Ltd+0.20+1.90%
Data as of 03/22/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$78.7M
Annual profit (last year)-$25.2M
Net profit margin-32.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs